Table 2.

Antibodies used for immunohistochemical analysis


Antibody

Source

Antigen retrieval (pH)

Dilution
CD3   Novocastra, Newcastle, United Kingdom   Citrate acid, 0.01 M, (6.0)   1:20  
CD10   Novocastra, Newcastle, United Kingdom   Citrate acid, 0.01 M, (6.0)   1:10  
CD20   Dako, Hamburg, Germany   Citrate acid, 0.01 M, (6.0)   1:5  
CD38   Novocastra, Newcastle, United Kingdom   Citrate acid, 0.01 M, (6.0)   1:100  
CD79   Dako, Hamburg, Germany   Citrate acid, 0.01 M, (6.0)   1:200  
MUM1/IRF4   Dako, Hamburg, Germany   Citrate acid, 0.01 M, (6.0)   1:50  
CD138/Syn-1   Dako, Hamburg, Germany   Citrate acid, 0.01 M, (6.0)   1:20  
BCL-2   Zytomed, Berlin, Germany   Citrate acid, 0.01 M, (6.0)   1:50  
LMP-1   Dako, Hamburg, Germany   TE buffer, (9.0)   1:200  
BCL-6   Dako, Hamburg, Germany   Target Retrieval Solution, (9.9)   1:10  
Ki-67
 
Hematopathology, Kiel, Germany41 
 
Citrate acid, 0.01 M, (6.0)
 
1:10
 

Antibody

Source

Antigen retrieval (pH)

Dilution
CD3   Novocastra, Newcastle, United Kingdom   Citrate acid, 0.01 M, (6.0)   1:20  
CD10   Novocastra, Newcastle, United Kingdom   Citrate acid, 0.01 M, (6.0)   1:10  
CD20   Dako, Hamburg, Germany   Citrate acid, 0.01 M, (6.0)   1:5  
CD38   Novocastra, Newcastle, United Kingdom   Citrate acid, 0.01 M, (6.0)   1:100  
CD79   Dako, Hamburg, Germany   Citrate acid, 0.01 M, (6.0)   1:200  
MUM1/IRF4   Dako, Hamburg, Germany   Citrate acid, 0.01 M, (6.0)   1:50  
CD138/Syn-1   Dako, Hamburg, Germany   Citrate acid, 0.01 M, (6.0)   1:20  
BCL-2   Zytomed, Berlin, Germany   Citrate acid, 0.01 M, (6.0)   1:50  
LMP-1   Dako, Hamburg, Germany   TE buffer, (9.0)   1:200  
BCL-6   Dako, Hamburg, Germany   Target Retrieval Solution, (9.9)   1:10  
Ki-67
 
Hematopathology, Kiel, Germany41 
 
Citrate acid, 0.01 M, (6.0)
 
1:10
 

or Create an Account

Close Modal
Close Modal